Tomoyuki Kitazaki

1.6k total citations
33 papers, 1.3k citations indexed

About

Tomoyuki Kitazaki is a scholar working on Organic Chemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, Tomoyuki Kitazaki has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Biochemistry. Recurrent topics in Tomoyuki Kitazaki's work include Synthesis and biological activity (8 papers), Synthesis of Tetrazole Derivatives (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Tomoyuki Kitazaki is often cited by papers focused on Synthesis and biological activity (8 papers), Synthesis of Tetrazole Derivatives (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). Tomoyuki Kitazaki collaborates with scholars based in Japan and United States. Tomoyuki Kitazaki's co-authors include Masayuki Ii, Yuji Iizawa, Hiroyuki Kimura, Tomohiro Kawamoto, Mie Sunamoto, Katsumi Itoh, Tsukasa Seya, Kazuyo Nakamura, Osamu Hazeki and Kaoru Hazeki and has published in prestigious journals such as PLoS ONE, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Tomoyuki Kitazaki

33 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoyuki Kitazaki Japan 16 525 343 260 209 156 33 1.3k
S A Gregory United States 17 519 1.0× 587 1.7× 101 0.4× 153 0.7× 185 1.2× 22 2.2k
Katsunori Takashima Japan 11 452 0.9× 242 0.7× 73 0.3× 155 0.7× 209 1.3× 12 963
Maria Allhorn Sweden 22 354 0.7× 700 2.0× 87 0.3× 113 0.5× 70 0.4× 31 1.6k
Rangaiah Shashidharamurthy United States 23 383 0.7× 615 1.8× 60 0.2× 140 0.7× 136 0.9× 54 1.5k
Soumya Panigrahi United States 21 387 0.7× 681 2.0× 43 0.2× 327 1.6× 154 1.0× 37 1.7k
David W. A. Beno United States 21 186 0.4× 491 1.4× 159 0.6× 294 1.4× 180 1.2× 54 1.4k
Shinya Abe Japan 18 267 0.5× 298 0.9× 89 0.3× 295 1.4× 321 2.1× 49 1.2k
Xiaoming Wu China 29 302 0.6× 1.5k 4.3× 393 1.5× 197 0.9× 235 1.5× 103 2.5k
Lucinda Furci Italy 17 365 0.7× 468 1.4× 45 0.2× 134 0.6× 137 0.9× 28 1.5k
Tjomme van der Bruggen Netherlands 19 406 0.8× 306 0.9× 33 0.1× 189 0.9× 144 0.9× 37 1.3k

Countries citing papers authored by Tomoyuki Kitazaki

Since Specialization
Citations

This map shows the geographic impact of Tomoyuki Kitazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Kitazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Kitazaki more than expected).

Fields of papers citing papers by Tomoyuki Kitazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Kitazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Kitazaki. The network helps show where Tomoyuki Kitazaki may publish in the future.

Co-authorship network of co-authors of Tomoyuki Kitazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Kitazaki. A scholar is included among the top collaborators of Tomoyuki Kitazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Kitazaki. Tomoyuki Kitazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oki, Hideyuki, Hiroaki Yashiro, Ken‐ichi Hamagami, et al.. (2022). Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity. Journal of Medicinal Chemistry. 65(12). 8456–8477. 4 indexed citations
2.
Kubo, Osamu, Kazuaki Takami, Masahiro Kamaura, et al.. (2021). Discovery of a novel series of GPR119 agonists: Design, synthesis, and biological evaluation of N-(Piperidin-4-yl)-N-(trifluoromethyl)pyrimidin-4-amine derivatives. Bioorganic & Medicinal Chemistry. 41. 116208–116208. 15 indexed citations
3.
Maki, Toshiyuki, Yoshinori Satomi, Megumi Hirayama, et al.. (2016). Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization. PLoS ONE. 11(3). e0150976–e0150976. 23 indexed citations
4.
Sato, Kenjiro, Osamu Kubo, Takeshi Yoshikawa, et al.. (2015). Optimization of a novel series of N-phenylindoline-5-sulfonamide-based acyl CoA:monoacylglycerol acyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities. Bioorganic & Medicinal Chemistry. 23(15). 4544–4560. 10 indexed citations
5.
Sato, Kenjiro, Takeshi Yoshikawa, Shinji Morimoto, et al.. (2015). Discovery of a Novel Series ofN-Phenylindoline-5-sulfonamide Derivatives as Potent, Selective, and Orally Bioavailable Acyl CoA:Monoacylglycerol Acyltransferase-2 Inhibitors. Journal of Medicinal Chemistry. 58(9). 3892–3909. 25 indexed citations
7.
Yamada, Masami, Takashi Ichikawa, Masayuki Ii, et al.. (2008). Novel cyclohexene derivatives as anti-sepsis agents: Synthetic studies and inhibition of NO and cytokine production. Bioorganic & Medicinal Chemistry. 16(7). 3941–3958. 32 indexed citations
8.
Kawamoto, Tomohiro, Masayuki Ii, Tomoyuki Kitazaki, Yuji Iizawa, & Hiroyuki Kimura. (2008). TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. European Journal of Pharmacology. 584(1). 40–48. 267 indexed citations
9.
Sunamoto, Mie, et al.. (2007). Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. European Journal of Pharmacology. 571(2-3). 231–239. 154 indexed citations
11.
Ii, Masayuki, Mie Sunamoto, Naoko Matsunaga, et al.. (2004). TAK-242 SUPPRESSES TOLL-LIKE RECEPTOR 4-MEDIATED CYTOKINE PRODUCTION AND PROTECTS MICE FROM ESCHERICHIA COLI-INDUCED LETHALITY. Critical Care Medicine. 32(Supplement). A15–A15. 3 indexed citations
12.
Kitamoto, Naomi, Yuji Iizawa, Takashi Ichikawa, et al.. (2002). Efficacy of TAK-457, a Novel Intravenous Triazole, against Invasive Pulmonary Aspergillosis in Neutropenic Mice. Antimicrobial Agents and Chemotherapy. 46(2). 283–287. 9 indexed citations
18.
Tsuchimori, Noboru, et al.. (1995). Optically Active Antifungal Azoles. V. Synthesis and Antifungal Activity of Stereoisomers of 3-Azolyl-2-(substituted phenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanols.. Chemical and Pharmaceutical Bulletin. 43(3). 441–449. 9 indexed citations
19.
Tasaka, Akihiro, Norikazu Tamura, Yoshihiro Matsushita, et al.. (1995). Optically Active Antifungal Azoles. IV. Synthesis and Antifungal Activity of (2R,3R)-3-Azolyl-2-(substituted phenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanols.. Chemical and Pharmaceutical Bulletin. 43(3). 432–440. 16 indexed citations
20.
Kitazaki, Tomoyuki, Tomoichiro Asano, Koichi Kato, S Kishimoto, & Kazuyuki Itoh. (1994). Synthesis and Human Immunodeficiency Virus(HIV)-1 protease Inhibitory Activity of Tripeptide Analogues Containing a Dioxoethylene Moiety.. Chemical and Pharmaceutical Bulletin. 42(12). 2636–2640. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026